Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Genitourinary Cancers
How are you integrating Prostox into your practice for prostate patients deciding between SBRT and hypofractionation?
Related Questions
What adjuvant treatment would you recommend for high-risk papillary RCC with a positive IVC margin?
Do you give Ra-223 (Xofigo) to patients diagnosed as having benign neutropenia (ANC 1.0-1.5) who are otherwise eligible to receive this radioisotope?
For a patient post-prostatectomy with a high PSA (>1), a negative MRI pelvis, and a negative PSMA PET scan, do you pursue any other imaging?
Would you treat someone following FLAME protocol for prostate cancer without fiducials if using daily CBCT?
For patients with metastatic RCC and gross hematuria from the primary tumor, what palliative radiation regimen would you recommend to help control the bleeding?
Would you consider re-irradiation in the setting of prior salvage prostatectomy after prostate brachytherapy?
Would you treat a patient with evidence of prostate cancer who refuses biopsy?
Would you recommend adjuvant radiation for a mucinous urachal adenocarcinoma s/p partial cystectomy and LN sampling with negative margins?
How long would you delay prostate radiation following use of a paclitaxel-eluting balloon dilator (optilume) for management of a recurrent urethral stricture after TURP?
If a patient diagnosed with seminoma after orchiectomy has margin positive disease noted in the spermatic cord and no overt metastasis on imaging and normal tumor markers, how should this patient be staged?
